What is the address of Docteur François DELVOYE, neurologue?

The registered office of Docteur François DELVOYE, neurologue is located at Boulevard Frère-Orban 47 box 22, 4000 Liège.

Is Docteur François DELVOYE, neurologue still active?

Yes. According to the CBE (3 October 2026) Docteur François DELVOYE, neurologue is active, legal situation “Normale toestand”, started on 28 September 2021.

Is Docteur François DELVOYE, neurologue registered on Peppol?

Yes, Docteur François DELVOYE, neurologue is registered on the Peppol network with ID 0208:0774651403.

What is the enterprise number of Docteur François DELVOYE, neurologue?

The enterprise number of Docteur François DELVOYE, neurologue is BE0774651403.

When was Docteur François DELVOYE, neurologue founded?

Docteur François DELVOYE, neurologue was founded on 28 September 2021.

Who are the directors of Docteur François DELVOYE, neurologue?

According to the 2025 annual accounts, the directors of Docteur François DELVOYE, neurologue are: François DELVOYE.

Is Docteur François DELVOYE, neurologue a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 September 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur François DELVOYE, neurologue make in 2025?

Docteur François DELVOYE, neurologue posted a profit after taxes of € 1,877 in financial year 2025.

What is the revenue of Docteur François DELVOYE, neurologue?

As a small company, Docteur François DELVOYE, neurologue is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,933.

Docteur François DELVOYE, neurologue (Private Limited)

Dossier Docteur François DELVOYE, neurologue, printed on 3 October 2026 from databakkes.be/en/0774651403/docteur-francois-delvoye-neurologue. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Docteur François DELVOYE, neurologue from Liège, company number BE0774651403, closed financial year 2025 with a result of € 1,877 after tax. For that financial year Docteur François DELVOYE, neurologue recorded a gross margin of € 19,933 and equity of € 5,000. Compared with financial year 2024, the result moved from € 38,673 to € 1,877. The company is profitable. The buffer shrank hard: equity is 97 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 28, 2026.

What it is worth Shrank hard

€ 5,000

▼ 97% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1,877

▼ 95% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,492

▼ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 166,350 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 15,080

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 12,728

▼ 46% vs 2024

€ 10,898 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 314

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,725

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 92,041 Gross margin 2022: € 92,041 First fiscal year in the series	€ 104,275 Gross margin 2023: € 104,275 ▲ 13% vs 2022 (€ 92,041) Favourable step	€ 64,660 Gross margin 2024: € 64,660 ▼ 38% vs 2023 (€ 104,275) Unfavourable step	€ 19,933 Gross margin 2025: € 19,933 ▼ 69% vs 2024 (€ 64,660) Unfavourable step	▼ 69%
Profit after taxes	€ 59,245 Profit after taxes 2022: € 59,245 First fiscal year in the series	€ 69,389 Profit after taxes 2023: € 69,389 ▲ 17% vs 2022 (€ 59,245) Favourable step	€ 38,673 Profit after taxes 2024: € 38,673 ▼ 44% vs 2023 (€ 69,389) Unfavourable step	€ 1,877 Profit after taxes 2025: € 1,877 ▼ 95% vs 2024 (€ 38,673) Unfavourable step	▼ 95%
Equity	€ 72,911 Equity 2022: € 72,911 First fiscal year in the series	€ 142,300 Equity 2023: € 142,300 ▲ 95% vs 2022 (€ 72,911) Favourable step	€ 169,474 Equity 2024: € 169,474 ▲ 19% vs 2023 (€ 142,300) Favourable step	€ 5,000 Equity 2025: € 5,000 ▼ 97% vs 2024 (€ 169,474) Unfavourable step	▼ 97%
Total debts	€ 74,970 Total debts 2022: € 74,970 First fiscal year in the series	€ 62,566 Total debts 2023: € 62,566 ▼ 17% vs 2022 (€ 74,970) Favourable step	€ 29,601 Total debts 2024: € 29,601 ▼ 53% vs 2023 (€ 62,566) Favourable step	€ 181,117 Total debts 2025: € 181,117 ▲ € 151,516 vs 2024 (€ 29,601) Unfavourable step	▲ € 151,516
Cash	€ 79,889 Cash 2022: € 79,889 First fiscal year in the series	€ 142,151 Cash 2023: € 142,151 ▲ 78% vs 2022 (€ 79,889) Favourable step	€ 160,162 Cash 2024: € 160,162 ▲ 13% vs 2023 (€ 142,151) Favourable step	€ 142,492 Cash 2025: € 142,492 ▼ 11% vs 2024 (€ 160,162) Unfavourable step	▼ 11%
Retained profit	€ 67,911 Retained profit 2022: € 67,911 First fiscal year in the series	€ 137,300 Retained profit 2023: € 137,300 ▲ 102% vs 2022 (€ 67,911) Favourable step	€ 164,474 Retained profit 2024: € 164,474 ▲ 20% vs 2023 (€ 137,300) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 164,474) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 11,500 Dividend 2024: € 11,500 Unchanged (€ 0) Unchanged	€ 166,350 Dividend 2025: € 166,350 ▲ € 154,850 vs 2024 (€ 11,500) Unchanged	▲ € 154,850
Bank debt	€ 44,619 Bank debt 2022: € 44,619 First fiscal year in the series	€ 34,121 Bank debt 2023: € 34,121 ▼ 24% vs 2022 (€ 44,619) Favourable step	€ 23,491 Bank debt 2024: € 23,491 ▼ 31% vs 2023 (€ 34,121) Favourable step	€ 12,728 Bank debt 2025: € 12,728 ▼ 46% vs 2024 (€ 23,491) Favourable step	▼ 46%
Balance sheet total	€ 147,881 Balance sheet total 2022: € 147,881 First fiscal year in the series	€ 204,866 Balance sheet total 2023: € 204,866 ▲ 39% vs 2022 (€ 147,881) Unchanged	€ 199,075 Balance sheet total 2024: € 199,075 ▼ 3% vs 2023 (€ 204,866) Unchanged	€ 186,117 Balance sheet total 2025: € 186,117 ▼ 7% vs 2024 (€ 199,075) Unchanged	▼ 7%

Key figures of Docteur François DELVOYE, neurologue, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur François DELVOYE, neurologue?

What happened at Docteur François DELVOYE, neurologue in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 28, 2026 New annual accounts for financial year 2025: profit of € 1,877 (▼ 95% vs 2024). Source: NBB ↗
Sep 28, 2021 New establishment in Liège. KBO
Sep 28, 2021 Start of the company according to the CBE. KBO

In short

From € 59,245 profit in 2022 to € 1,877 profit in 2025.

Paid € 53,103 in corporate taxes since 2022.

Best year ever: 2023, with € 69,389 profit.

Paid out € 177,850 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur François DELVOYE, neurologue? We notify you, reason included.

Follow Docteur François DELVOYE, neurologue

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

François DELVOYE

Docteur François DELVOYE, neurologue

Behind Docteur François DELVOYE, neurologue is François DELVOYE.

See the full network in the app

Directors

According to the 2025 annual accounts

François DELVOYE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Boulevard Frère-Orban 47 box 22

4000 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0774.651.403
VAT number: BE 0774.651.403
Registered office: Boulevard Frère-Orban 47 bus 22, 4000 Liège
Names & denominations: Docteur François DELVOYE, neurologue
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 September 2021
Peppol: Active · Active since 20 Feb 2026
Contact: [email protected] +32478457645

View on CBE Public ↗ Annual accounts (NBB) ↗